James Shin
Stock Analyst at Deutsche Bank
(1.70)
# 3,136
Out of 4,761 analysts
20
Total ratings
44.44%
Success rate
0.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $109.95 | +9.14% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $89.50 | +17.32% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $873.68 | +16.18% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $303.01 | +0.66% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $72.11 | -16.79% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $55.83 | -19.40% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $39.70 | +51.13% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $202.08 | -25.77% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $700.33 | +14.23% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $1.95 | +412.82% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.77 | +577.97% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $1.04 | +6,630.77% | 1 | Dec 12, 2022 |
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $109.95
Upside: +9.14%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $89.50
Upside: +17.32%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $873.68
Upside: +16.18%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $303.01
Upside: +0.66%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $72.11
Upside: -16.79%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $55.83
Upside: -19.40%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $39.70
Upside: +51.13%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $202.08
Upside: -25.77%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $700.33
Upside: +14.23%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.95
Upside: +412.82%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $1.77
Upside: +577.97%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $1.04
Upside: +6,630.77%